CSIMarket
Baxter International Inc   (NYSE: BAX)
Other Ticker:  
 
 

Baxter International Inc 's Yearly Capital Expenditures Growth 5 Years

 

 

Select the Comparisons : Select the Ratio:



BAX Annual Capital Expenditures Growth

2024
2023
2022
2021
2020
Y / Y Annual Capital Expenditures Change -35.55 % 1.91 % -8.61 % 4.8 % 267.36 %
Annual Capital Expenditures (in millions $) $446.00 $692.00 $679.00 $743.00 $709.00


Annual Capital Expenditures Growth Comment
Baxter International Inc experienced detoriation of Annual Capital Expenditures for the fiscal year ended 2024 by -35.55% to $ 446.00 millions, compare to $ 692.00 in Annual Capital Expenditures reported in the previous year. The decline in company's annual Capital Expenditures accelerated, from the 1.91 % gain, in the fiscal year ended 2023.

Baxter International Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2024 Annual Capital Expenditures within Healthcare SectorY/Y Capital Expenditures Growth %2024 Annual Capital Expenditures
Johnson and Johnson -2.62 %$ 4,424.000  millions
Pfizer Inc -25.54 %$ 2,909.000  millions
Merck and Co Inc -12.71 %$ 3,372.000  millions
Abbott Laboratories  0.23 %$ 2,207.000  millions
3m Company -26.87 %$ 1,181.000  millions
Medtronic Plc  8.77 %$ 1,587.000  millions
Bristol myers Squibb Company  3.23 %$ 1,248.000  millions
Amgen Inc -1.44 %$ 1,096.000  millions
Intuitive Surgical Inc   4.42 %$ 1,111.200  millions
Takeda Pharmaceutical Company Limited  23.10 %$ 1,199.978  millions
Abbvie Inc   25.35 %$ 974.000  millions
Tenet Healthcare Corp  23.97 %$ 931.000  millions
Universal Health Services Inc   26.92 %$ 943.810  millions
Boston Scientific Corporation  11.11 %$ 790.000  millions
Moderna Inc   48.66 %$ 1,051.000  millions
Select Medical Holdings Corp -3.06 %$ 222.177  millions
Sotera Health Company -16.36 %$ 179.070  millions
Quidelortho Corp -6.70 %$ 195.100  millions
Illumina Inc -34.69 %$ 128.000  millions
Align Technology inc -35.03 %$ 115.580  millions
Arrowhead Pharmaceuticals Inc -19.89 %$ 141.469  millions
Qiagen N v   5.56 %$ 171.242  millions
Bio rad Laboratories Inc   5.77 %$ 165.600  millions
Teladoc Health Inc -20.51 %$ 124.052  millions
Elanco Animal Health Incorporated  4.55 %$ 161.000  millions
Transmedics Group Inc -14.57 %$ 129.744  millions
Henry Schein Inc   0.68 %$ 148.000  millions
Avantor Inc   1.37 %$ 148.800  millions
Icon Plc  20.00 %$ 168.060  millions
Dr Reddy s Laboratories Limited  42.75 %$ 197.000  millions
Resmed Inc -14.93 %$ 114.856  millions
Idexx Laboratories Inc -2.26 %$ 130.922  millions
Exact Sciences Corporation  8.87 %$ 135.989  millions
Enovis Corp  47.54 %$ 180.714  millions
Ptc Therapeutics inc -38.33 %$ 74.249  millions
Integer Holdings Corporation -11.76 %$ 105.607  millions
National Vision Holdings Inc -16.67 %$ 95.505  millions
Haemonetics Corporation -40.00 %$ 66.296  millions
Insulet Corporation  22.94 %$ 134.000  millions
Biomarin Pharmaceutical Inc -9.35 %$ 97.418  millions
Mettler Toledo International Inc -1.90 %$ 103.898  millions
Perrigo Company Plc  16.83 %$ 118.300  millions
Icu Medical Inc -3.23 %$ 90.206  millions
Lantheus Holdings Inc   75.82 %$ 160.536  millions
Hologic Inc -9.89 %$ 82.400  millions
Teleflex Incorporated  38.46 %$ 126.434  millions
Surgery Partners Inc   2.27 %$ 90.400  millions
Masimo Corp -41.38 %$ 51.100  millions
Sarepta Therapeutics Inc   67.82 %$ 146.956  millions
Alphatec Holdings Inc   8.14 %$ 93.136  millions
Globus Medical Inc   47.44 %$ 115.429  millions
Abcellera Biologics Inc   1.30 %$ 78.396  millions
Integra Lifesciences Holdings Corp  72.73 %$ 114.371  millions
Neogen Corporation  70.77 %$ 111.421  millions
Amneal Pharmaceuticals Inc   1.54 %$ 66.574  millions
Patterson Companies Inc   4.69 %$ 67.626  millions
Chemed Corporation -12.50 %$ 49.531  millions
Warby Parker Inc   20.75 %$ 64.032  millions
Incyte Corporation  112.77 %$ 100.163  millions
Msa Safety Inc  28.57 %$ 54.223  millions

Other Companies within Healthcare Sector and their 2024 Capital Expenditures

Y/Y Annual Capital Expenditures Growth %

2024 Capital Expenditures
Avid Bioservices Inc -59.74 %$ 31.805  millions
Myriad Genetics Inc -60.27 %$ 29.700  millions
Alnylam Pharmaceuticals Inc -45.16 %$ 34.277  millions
Orthofix Medical Inc -45.16 %$ 34.876  millions
Novavax inc -75.86 %$ 14.639  millions
Envista Holdings Corporation -43.10 %$ 33.800  millions
Phibro Animal Health Corporation -19.61 %$ 41.238  millions
Emergent Biosolutions Inc -56.86 %$ 22.900  millions
Alkermes Plc -31.25 %$ 33.484  millions
Ultragenyx Pharmaceutical Inc -58.70 %$ 19.991  millions
Cryoport inc -52.27 %$ 21.267  millions
Mannkind Corporation -78.57 %$ 9.693  millions
Travere Therapeutics Inc -14.29 %$ 36.212  millions
Atricure Inc -43.90 %$ 23.459  millions
Option Care Health Inc -14.63 %$ 35.606  millions
Kodiak Sciences Inc 0.00 %$ 0.375  millions
Lifestance Health Group Inc -47.50 %$ 21.566  millions
Exelixis Inc -30.00 %$ 28.435  millions
Irhythm Technologies Inc -17.50 %$ 33.942  millions
Fortrea Holdings Inc -37.50 %$ 25.500  millions
Amphastar Pharmaceuticals Inc   7.89 %$ 41.041  millions
Merit Medical Systems Inc  5.56 %$ 38.043  millions
Medpace Holdings Inc 0.00 %$ 36.548  millions
Kymera Therapeutics Inc -64.71 %$ 12.838  millions
Prokidney Corp -14.71 %$ 29.509  millions
Beam Therapeutics Inc -75.76 %$ 8.946  millions
Pediatrix Medical Group Inc -33.33 %$ 22.022  millions
Hutchmed china Limited -46.88 %$ 17.933  millions
Agilon Health Inc   36.67 %$ 41.285  millions
Immunitybio inc -80.00 %$ 6.888  millions
Neurocrine Biosciences Inc   35.71 %$ 38.200  millions
Nkarta Inc -85.71 %$ 4.409  millions
National Healthcare Corp 0.00 %$ 27.600  millions
Twist Bioscience Corporation -81.48 %$ 5.076  millions
Inotiv Inc -18.52 %$ 22.310  millions
Novocure Limited  55.56 %$ 42.855  millions
Tandem Diabetes Care Inc -26.92 %$ 19.231  millions





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com